1 / 47

THERAPY & MANAGEMENT ASTHMA & COPD

THERAPY & MANAGEMENT ASTHMA & COPD. Dr. Mike Iredale October 2010. www.brit-thoracic.org.uk www.asthma.org.uk. ASTHMA.

ember
Download Presentation

THERAPY & MANAGEMENT ASTHMA & COPD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. THERAPY & MANAGEMENTASTHMA & COPD Dr. Mike Iredale October 2010

  2. www.brit-thoracic.org.ukwww.asthma.org.uk

  3. ASTHMA • “a chronic inflammatory disorder of the airways….in susceptible individuals, inflammatory symptoms are usually associated with widespread but variable airflow obstruction and an increase in airway response to a variety of stimuli. Obstruction is often reversible, either spontaneously or with treatment.”

  4. ACUTE ASTHMA • Assessment • - able to complete sentences ? • - peak expiratory flow rate • - respiratory rate • - pulse • - oxygen saturation • - arterial blood gases

  5. ACUTE ASTHMA - Treatment • Oxygen - high flow / concentration • Nebulised (high dose) B2-agonist • - salbutamol • - terbutaline

  6. ACUTE ASTHMA - Treatment (2) • Steroids • - prednisolone (40-50 mg daily) • - hydrocortisone (100mg qds) • no need to taper dose • continue inhaled steroid

  7. ACUTE ASTHMA - Treatment (3) • Ipratropium Bromide • - nebulised 500mcg qds • - acute severe asthma • - life-threatening asthma • - poor initial response to nebulised B2-agonist • - only for initial phase of treatment

  8. ACUTE ASTHMA - Treatment (4) • Intravenous Magnesium Sulphate • - 1.2 - 2g IV infusion over 20 min (single dose) • consider if: • life-threatening or near fatal asthma • acute severe asthma with poor initial response • after consultation with senior medical staff

  9. ACUTE ASTHMA - Treatment (5) • Intravenous Infusions • Aminophylline - 0.5 mg / kg / hr • - omit bolus if on oral aminohylline / theophylline • - check levels • B2-agonist - limited evidence • - ventilated patients

  10. ACUTE ASTHMA - Treatment (6) • Antibiotics • Routine prescription of antibiotics is • NOT • indicated for acute asthma.

  11. ACUTE ASTHMA • ITU Referral: • - deteriorating peak flow • - persisting / worsening hypoxia • - hypercapnea • - falling pH on ABG • - exhaustion / feeble respiration • - drowsiness, confusion, coma, cardiac arrest

  12. ACUTE ASTHMA • Discharge: • - on discharge medication for 24 hours • - PEF >75% best/predicted + <25% variability • - oral + inhaled steroid + bronchodilator • - inhaler technique checked • - PEF meter + action plan • - follow up: GP 2 days, chest clinic 4 weeks

  13. Questions ?

  14. CHRONIC ASTHMA • Treatment Goals: • - minimal symptoms during day & night • - minimal need for reliever medication • - no exacerbations • - no limitation of physical activity • - normal lung function • (FEV1 / PEF > 80% predicted or best)

  15. CHRONIC ASTHMA • Non-Pharmacology • - smoking cessation (active / passive) • - allergen avoidance • - complementary / alternative medicine • - weight reduction in obese • - gastro-oesophageal reflux • - immunotherapy

  16. CHRONIC ASTHMA • Pharmacology • - step-wise approach • - start at level appropriate to severity • - step-down when control is good • - compliance, inhaler technique, trigger factors

  17. CHRONIC ASTHMA • STEP 1: Mild Intermittent Asthma • inhaled short-acting B2-agonist • - as required • - reliever therapy

  18. CHRONIC ASTHMA • STEP 2: Introduction of Regular Preventer Therapy • inhaled steroid is first choice • - 400-800 mcg BDP (beclomethasone) equivalent

  19. CHRONIC ASTHMA • Inhaled Steroids: • - beclomethasone (BDP) • - budesonide • - fluticasone • - mometasone • - ciclesonide • - large volume spacer in doses >1500 mcg BDP

  20. CHRONIC ASTHMA • STEP 3: Add-on therapy • long-acting B2-agonist • - salmeterol • - formoterol • - good response - continue • no response - stop

  21. CHRONIC ASTHMA • STEP 3: Add-on therapy (2) • if control remains inadequate: • - increase inhaled steroid to 800 mcg / day

  22. CHRONIC ASTHMA • STEP 3: Add-on therapy (3) • if control remains inadequate trial of: • - leukotriene receptor antagonists • - theophylline

  23. CHRONIC ASTHMA • STEP 4: Poor control on moderate dose inhaled steroid + add-on therapy: Addition of 4th drug • - increase inhaled steroid to 2000 mcg / day • - leukotriene receptor antagonists • - theophylline • - slow-release oral B2-agonist

  24. CHRONIC ASTHMA • STEP 5: Continuous or Frequent use of Oral Steroid • - side-effects • - steroid sparing medication • - inhaled steroid most effective • - immunosuppressants

  25. CHRONIC ASTHMA • Step Down • - patients often left over treated • - regular review • - aim to maintain at lowest dose inhaled • steroid that keeps asthma controlled

  26. Questions ?

  27. COPD • ..is a chronic, slowly progressive disorder characterised by airflow obstruction (reduced FEV1 and FEV1/VC ratio) that does not change markedly over several months. Most of the lung function impairment is fixed, although some reversibility can be produced by bronchodilator (or other) therapy.

  28. COPD - Treatment • SMOKING CESSATION • ..is the single most important way of affecting outcome in patients at all stages of COPD

  29. COPD - Treatment (2) • Bronchodilators (BD) • - stepwise approach • - stop therapy if ineffective • short acting as needed (B2-agonist or AC) • combination short acting BD • long-acting BD (B2-agonist or AC)

  30. COPD - Treatment (2) • Bronchodilators - Mod/severe COPD: consider - • combination long-acting BD + inhaled steroid • theophylline

  31. COPD - Treatment (3) • Frequent exacerbations: • optimise BD therapy with one or more long-acting BD (B2-agonist or AC) • inhaled steroid - if FEV1 < 50% + 2 exacerbations in last year

  32. COPD - Treatment (4) Other measures: - nutrition - vaccination - pulmonary rehabilitation - breathlessness treatment - surgery - mucolytic therapy - depression

  33. COPD - Treatment (5) • Long Term Oxygen Therapy (LTOT): • - improved survival (25% - 41% 5 yr) • - less secondary polycythaemia • - prevents progression of pulmonary • hypertension • - better neuropsychological health

  34. COPD - Treatment (5) • Long Term Oxygen Therapy (LTOT): • - FEV1 < 1.5 l • - paO2 < 7.3 kPa, on 2 occasions 3 weeks apart • - at least 15 hrs each day • - no benefit if continue to smoke

  35. Questions ?

  36. COPD - Acute Exacerbation • Presentation: Important symptoms include • - increased sputum purulence • - increased sputum volume • - increased dyspnoea • - increased wheeze • - chest tightness • - fluid retention

  37. COPD - Acute Exacerbation • Treatment: Bronchodilators • - nebulised in hospital + regular • - B2-agonist / anticholinergic • - acute response does not imply long-term benefit • - iv aminophylline if severe and not • responding

  38. COPD - Acute Exacerbation • Treatment: Antibiotic • if 2 or more of • - increased breathlessness • - increased sputum volume • - development of purulent sputum

  39. COPD - Acute Exacerbation • Treatment: Antibiotic • commonest bacterial causes • - Haemophilus influenzae • - Streptococcus pneumoniae • amoxycillin first choice for most patients

  40. COPD - Acute Exacerbation • Treatment: Steroid • - common practice but value unclear • Justified if: • - already on oral steroid • - previous documented response • - first presentation of airways obstruction • - AFO fails to respond to increase bronchodilator

  41. COPD - Acute Exacerbation • Treatment: • Diuretic • - peripheral oedema • - raised JVP • Anticoagulant • - prophylactic clexane for acute on chronic • respiratory failure

  42. COPD - Acute Exacerbation • Treatment: OXYGEN • ? resp. failure - oxygen saturation • - pO2 < 8 kPa, SaO2 < 92% • ? type of resp failure - ABG • - type 1: normal or low pCO2 • - type 2: raised pCO2

  43. COPD - Acute Exacerbation • Treatment: OXYGEN • type 1 - high concentration oxygen • - monitor with SaO2 unless patient deteriorates • - aim to keep SaO2 >94-98 %

  44. COPD - Acute Exacerbation • Treatment: OXYGEN • type 2 - controlled oxygen therapy • - 24 % FiO2 , repeat ABG after 60 min • - if pO2 > 8 kPa + pCO2 & pH ISQ - no change • - if pO2 < 8 kPa + pCO2 & pH ISQ - increase to 28% • - if pCO2 increases & pH falls - alternative strategy

  45. COPD - Acute Exacerbation Alternative strategies for COPD & respiratory failure: - non-invasive ventilation (NIV) (pH < 7.35, pCO2 > 6) - intubation and ventilation (- iv doxapram)

  46. Questions ?

  47. www.brit-thoracic.org.ukwww.asthma.org.uk

More Related